Navigation Links
Good Diet Can Be An Alternate To Drugs In Lowering Cholesterol

Scientists in Canada has said that choosing and eating the right kind of food can be an alternate to drug therapy in lowering the cholesterol level//.

David Jenkins and other researchers at the University of Toronto studied people who ate a diet high in viscous fibres, soy protein, almonds and plant sterol margarine -- all thought to help lower cholesterol, reported the health portal Health Day News.

The participants, including 66 women and men, averaging just over 59 years of age, were told to follow the diet for a year and keep records of what they ate.

They met every two months with the researchers to discuss their progress and have their cholesterol levels measured.

After a year, more than 30 percent of the study volunteers had successfully kept to the diet and lowered their cholesterol levels by over 20 percent, the researchers say.

That's comparable to what some of the volunteers achieved after taking a cholesterol-lowering statin drug for a month before they started on the diet, according to the finding that has appeared in the current issue of the American Journal of Clinical Nutrition.

"The average person can do a lot to improve their health through diet," Jenkins said.

--Edited IANS
'"/>




Page: 1

Related medicine news :

1. San Francisco Mayor Proposes An Alternate Plan For The Uninsured City Residents
2. Will Baby Jabs Play Truant? NHS Says “No”, Alternate Systems in Plae
3. Alternate ways to produce HAS from tobacco plants
4. Nobel Laureate Finds an Alternate Way to Manufacture Anti-Flu Drug
5. Yoga The Best Alternate For Stress: Ramdev
6. Nepali Rhesus May be Used as an Alternate for HIV/AIDS Research
7. Travellers Cautioned Over The Alternate Remedies For Malaria
8. Crackdown on Alternate Health Practitioners
9. Lean Protein Could Be Key to Obesity Drugs
10. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
11. Nasal Spray Could Take Drugs Direct to Brain.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... compare student test score performance for the 2015-16 school year across Wisconsin’s public ... programs. Though it highlights important patterns in student test score performance, the report’s ...
(Date:4/25/2017)... ... 25, 2017 , ... As pharmaceutical companies are held to ... process innovation in drug formulation and manufacturing. CoreRx offers its clients more ... in support of their development and manufacturing goals. , The company was ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the ... or chronic problems, I focus on preventative care with all my patients to alleviate possible ... questions, always feel free to contact my office and my trained staff will assist you ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
Breaking Medicine Technology: